KPTI
4:05 PM
Catalyst Calendar
Wed, Jul 1, 2026
1 updatesWed, Jun 3, 2026
1 updatesTue, Jun 2, 2026
2 updatesKPTI
10:02 AM
Karyopharm's Phase 3 SENTRY Trial of Selinexor Plus Ruxolitinib in Myelofibrosis Selected for Late-Breaking Oral Presentation at EHA 2026
Presentation / Abstract • Phase 3Late-Breaking Oral Presentation Sun, Jun 14, 2026, 9:15 AM CESTkaryopharm.com
KPTI
8:59 AM
Mon, Jun 1, 2026
2 updatesThu, May 28, 2026
1 updatesKPTI
7:30 AM
Thu, May 14, 2026
1 updatesKPTI
7:30 AM
Karyopharm Reports First Quarter 2026 Financial Results and Completion of Phase 3 Endometrial Cancer Trial Enrollment
Enrollment • Phase 3Enrollment completion Thu, May 14, 2026karyopharm.com
Tue, May 12, 2026
1 updatesKPTI
7:30 AM
Thu, May 7, 2026
1 updatesKPTI
7:30 AM
Tue, Apr 21, 2026
1 updatesKPTI
10:32 AM
Karyopharm's Phase 3 SENTRY Trial in Myelofibrosis Selected for Late-Breaking Oral Presentation at ASCO 2026 Annual Meeting
Presentation / Abstract • Phase 3karyopharm.com